Pharmaceutical Industry

MADDOX Pharma Swiss GmbH 

Bellinzona · Since 2015

The core activity of Maddox Pharma Swiss is the development, manufacture and marketing of health products, particularly pharmaceuticals and dietary supplements, with the aim of improving people's quality of life and creating stakeholder value.

MAS pharma SA 

Pambio-Noranco · Since 2015

Matrixsanos Sàrl 

Eysins · Since 1996

Matrixsanos Sàrl manufactures chromopuncture instruments, ultrasonic devices to deter martens, and instruments for producing silver and copper colloids. The company supplies specialized products for therapists and for personal use.

Maurice Lacroix, succursale de Medinova SA 

Saignelégier · Since 2022

Maurice Lacroix, succursale de Medinova SA designs, manufactures and sells Swiss-made wristwatches and related accessories. The company offers multiple watch collections and provides after‑sales services including maintenance, repairs, user manuals and authorised service centres.

Maylen Farma SA 

Viganello · Since 2013

The core activity of Maylen Farma SA is the development, manufacture and marketing of pharmaceutical products.

Medical Pharma Services, s.r.o., Prag, Zweigniederlassung Risch 

Rotkreuz · Since 2019

MphaR provides Medical Affairs services to pharmaceutical companies, aiming to support the introduction of innovative therapies and medical products. The core activities include: Strategic planning and execution of medical events, such as advisory boards and educational events; Development of digital solutions for Medical Affairs, such as virtual collaboration platforms; Support for clinical trials and product development; Provision of services in the areas of oncology, neurology, rare diseases, immunology and vaccines, respiratory diseases and COPD, endocrinology and diabetes. The company focuses on providing innovative solutions to accelerate product development, maximize global reach, and minimize environmental impact.

Medicoop SA 

Geneva · Since 2019

Medicoop SA supplies original, CE‑marked medical devices through B2B procurement channels within the EU. It serves hospitals, clinics and healthcare procurement organizations with essential medical products in volume and does not engage with private individuals or individual practitioners.

Medicor AG 

Cham · Since 1993

MediCrops AG 

Pfäffikon Sz · Since 2019

The core activity of MediCrops AG is the development and provision of medical cannabis products and therapies. The company focuses on researching and developing innovative products that meet the needs of patients, and aims to revolutionize patient care by optimizing cannabis therapies.

Medinova AG 

Zurich · Since 1945

The core activity of Medinova AG is the marketing and distribution of pharmaceutical products, in particular prescription-only medicines (Rx) and over-the-counter products (OTC/medical devices), with the goal of improving people's quality of life.

Medistri SA 

Domdidier · Since 2006

The core activity of Medistri is to provide sterilization and laboratory services to the healthcare industry, particularly to companies in the fields of pharmacy, medical technology, biotechnology, and aerospace. This includes specialized services such as sterilization, manufacturing, packaging, validation, and laboratory services. The company supports customers in the development and scaling of healthcare products and provides infrastructure for start-ups and established companies to facilitate their global expansion.

MEDITOP Switzerland AG 

Eich · Since 2022

The core activity of MEDITOP Switzerland AG is the development, manufacture, marketing and contract manufacturing of pharmaceuticals and pharmaceutical products, in particular for niche markets, as well as the provision of pharmaceutical services such as drug approval, packaging and distribution of test preparations.

Medius AG 

Muttenz · Since 1997

The core activity of Medius AG is to provide services in the field of regulatory affairs for pharmaceuticals and health products, including market authorization, quality assurance and development. The company particularly supports international companies in their market entry into Switzerland and offers consulting and services in these areas.

Medvisis Switzerland AG 

Hägendorf · Since 2023

Medvisis Switzerland AG is a healthcare company that registers and commercializes pharmaceutical products from international pharmaceutical and biotech firms. It focuses on specialty, rare-disease and hospital products and provides in-licensing or commercialization agreements, product registration with Swissmedic, reimbursement and market-access support, and commercialization supported by a network of key opinion leaders.

Melodia Therapeutics AG 

Basel · Since 2024

Melodia Therapeutics AG is developing a next-generation DPP1 inhibitor to treat severe neutrophil-driven inflammatory diseases. The company focuses on selective, non‑covalent inhibition of DPP1 and is advancing therapies for respiratory, dermatologic and systemic inflammatory disorders.

Merck Sharp & Dohme (Switzerland) GmbH 

Lucerne · Since 2008

Merck Sharp & Dohme (Switzerland) GmbH is a research-driven biopharmaceutical company that develops, manufactures and distributes medicines and vaccines. The company focuses on therapeutic areas including oncology, infectious diseases and cardio-metabolic disorders, and coordinates clinical trials and local services in Switzerland.

Merck Sharp & Dohme Research GmbH 

Lucerne · Since 1963

Merck Sharp & Dohme Research GmbH is a biopharmaceutical research company focused on scientific innovation to discover, develop and provide medicines and vaccines, and to conduct clinical research across therapeutic areas such as oncology, infectious diseases and cardiometabolic disorders.

Merck Sharp & Dohme IDEA GmbH 

Lucerne · Since 1991

Merck Sharp & Dohme IDEA GmbH is a biopharmaceutical company focused on the discovery, development and provision of medicines and vaccines. It conducts clinical research, develops biological therapeutics and supports the production and supply of pharmaceutical and vaccine products.

Merz Pharma (Schweiz) AG 

Allschwil · Since 1977

The core activity of Merz Therapeutics is the development, manufacture and marketing of pharmaceuticals, particularly in the fields of neurology, hepatology and dermatology. The company focuses on researching and developing innovative therapies to improve the quality of life for patients.

metaLead Therapeutics AG 

Basel · Since 2023

The core activity of metaLead Therapeutics AG is the development of innovative, safe and effective medicines for the treatment of diseases caused by the accumulation of heavy metals such as lead, mercury and copper. The company focuses particularly on the development of chelation therapies that specifically target certain heavy metals and can remove them from the body without affecting essential metals. The company's products aim to revolutionize the treatment of diseases such as lead poisoning and Wilson's disease, and improve the quality of life for patients.